Switch to:
Also traded in: Australia, Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.71
RMD's Cash-to-Debt is ranked lower than
64% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. RMD: 0.71 )
Ranked among companies with meaningful Cash-to-Debt only.
RMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.33  Med: 2.91 Max: No Debt
Current: 0.71
Equity-to-Asset 0.54
RMD's Equity-to-Asset is ranked lower than
61% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. RMD: 0.54 )
Ranked among companies with meaningful Equity-to-Asset only.
RMD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.74 Max: 0.86
Current: 0.54
0.34
0.86
Interest Coverage 40.83
RMD's Interest Coverage is ranked higher than
53% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.06 vs. RMD: 40.83 )
Ranked among companies with meaningful Interest Coverage only.
RMD' s Interest Coverage Range Over the Past 10 Years
Min: 38.28  Med: 111.33 Max: No Debt
Current: 40.83
Piotroski F-Score: 5
Altman Z-Score: 6.09
Beneish M-Score: -2.45
WACC vs ROIC
6.68%
16.32%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 20.56
RMD's Operating Margin % is ranked higher than
87% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. RMD: 20.56 )
Ranked among companies with meaningful Operating Margin % only.
RMD' s Operating Margin % Range Over the Past 10 Years
Min: 12.59  Med: 21.76 Max: 26.05
Current: 20.56
12.59
26.05
Net Margin % 15.96
RMD's Net Margin % is ranked higher than
89% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. RMD: 15.96 )
Ranked among companies with meaningful Net Margin % only.
RMD' s Net Margin % Range Over the Past 10 Years
Min: 9.26  Med: 18.44 Max: 22.2
Current: 15.96
9.26
22.2
ROE % 18.60
RMD's ROE % is ranked higher than
88% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. RMD: 18.60 )
Ranked among companies with meaningful ROE % only.
RMD' s ROE % Range Over the Past 10 Years
Min: 7.94  Med: 15.55 Max: 21.47
Current: 18.6
7.94
21.47
ROA % 10.27
RMD's ROA % is ranked higher than
86% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. RMD: 10.27 )
Ranked among companies with meaningful ROA % only.
RMD' s ROA % Range Over the Past 10 Years
Min: 5.87  Med: 12.21 Max: 15.54
Current: 10.27
5.87
15.54
ROC (Joel Greenblatt) % 57.24
RMD's ROC (Joel Greenblatt) % is ranked higher than
88% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. RMD: 57.24 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
RMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 19.19  Med: 42.13 Max: 58.32
Current: 57.24
19.19
58.32
3-Year Revenue Growth Rate 7.90
RMD's 3-Year Revenue Growth Rate is ranked higher than
66% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. RMD: 7.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
RMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.9  Med: 23.2 Max: 32.3
Current: 7.9
7.9
32.3
3-Year EBITDA Growth Rate 5.80
RMD's 3-Year EBITDA Growth Rate is ranked higher than
50% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. RMD: 5.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
RMD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 5.8  Med: 23 Max: 76.3
Current: 5.8
5.8
76.3
3-Year EPS without NRI Growth Rate 5.80
RMD's 3-Year EPS without NRI Growth Rate is ranked higher than
53% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. RMD: 5.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
RMD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 21.6 Max: 66.7
Current: 5.8
0
66.7
GuruFocus has detected 4 Warning Signs with ResMed Inc $RMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» RMD's 30-Y Financials

Financials (Next Earnings Date: 2017-07-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

RMD Guru Trades in Q2 2016

Columbia Wanger 1,045,999 sh (New)
Joel Greenblatt 262,958 sh (+133.85%)
Ken Fisher 20,950 sh (unchged)
John Hussman 2,300 sh (unchged)
Steven Cohen Sold Out
Ray Dalio Sold Out
Jim Simons 788,700 sh (-38.53%)
Paul Tudor Jones 8,245 sh (-53.76%)
» More
Q3 2016

RMD Guru Trades in Q3 2016

Paul Tudor Jones 17,487 sh (+112.09%)
Jim Simons 1,421,600 sh (+80.25%)
Joel Greenblatt 296,383 sh (+12.71%)
Ken Fisher 20,950 sh (unchged)
John Hussman 2,300 sh (unchged)
Columbia Wanger 1,023,346 sh (-2.17%)
» More
Q4 2016

RMD Guru Trades in Q4 2016

Ken Fisher 20,950 sh (unchged)
John Hussman 2,300 sh (unchged)
Paul Tudor Jones Sold Out
Columbia Wanger 686,101 sh (-32.96%)
Jim Simons 385,300 sh (-72.90%)
Joel Greenblatt 12,933 sh (-95.64%)
» More
Q1 2017

RMD Guru Trades in Q1 2017

Paul Tudor Jones 24,495 sh (New)
Caxton Associates 6,800 sh (New)
Steven Cohen 800 sh (New)
Ken Fisher 20,950 sh (unchged)
John Hussman Sold Out
Columbia Wanger 640,313 sh (-6.67%)
Joel Greenblatt 9,715 sh (-24.88%)
Jim Simons 32,700 sh (-91.51%)
» More
» Details

Insider Trades

Latest Guru Trades with RMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NYSE:COO, OTCPK:SAUHY, NAS:HOLX, NYSE:WST, OTCPK:OCPNY, NYSE:STE, NYSE:WAT, OTCPK:TRUMY, NAS:XRAY, OTCPK:GNGBF, NYSE:HRC, NYSE:MTD, NAS:ICUI, NYSE:CMD, OTCPK:ANSLY, NAS:PODD, NYSE:HAE, OTCPK:CLPBY, OTCPK:TOPCF, NYSE:HYH » details
Traded in other countries:RMD.Australia, RME.Germany, RSMDF.USA,
Headquarter Location:USA
ResMed Inc is a developer, manufacturer and distributor of medical products for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders.

ResMed develops, manufactures, and distributes medical devices--such as airflow generators and masks--to treat breathing disorders. It also markets ventilation products, but sleep apnoea remains the company's primary focus. ResMed's reach is truly global, with distribution capabilities in more than 70 countries through wholly owned and independent firms. An increasing proportion of manufacturing capacity is in Singapore, with some still in Australia, where the company was founded.

Ratios

vs
industry
vs
history
PE Ratio 30.36
RMD's PE Ratio is ranked higher than
55% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. RMD: 30.36 )
Ranked among companies with meaningful PE Ratio only.
RMD' s PE Ratio Range Over the Past 10 Years
Min: 16.93  Med: 23.52 Max: 66.38
Current: 30.36
16.93
66.38
Forward PE Ratio 20.24
RMD's Forward PE Ratio is ranked higher than
77% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.42 vs. RMD: 20.24 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 30.36
RMD's PE Ratio without NRI is ranked higher than
55% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.38 vs. RMD: 30.36 )
Ranked among companies with meaningful PE Ratio without NRI only.
RMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 16.93  Med: 23.5 Max: 64.76
Current: 30.36
16.93
64.76
Price-to-Owner-Earnings 31.05
RMD's Price-to-Owner-Earnings is ranked higher than
56% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.93 vs. RMD: 31.05 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
RMD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.88  Med: 23.73 Max: 74.05
Current: 31.05
12.88
74.05
PB Ratio 5.31
RMD's PB Ratio is ranked lower than
75% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. RMD: 5.31 )
Ranked among companies with meaningful PB Ratio only.
RMD' s PB Ratio Range Over the Past 10 Years
Min: 2.29  Med: 3.67 Max: 6.86
Current: 5.31
2.29
6.86
PS Ratio 4.86
RMD's PS Ratio is ranked lower than
66% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. RMD: 4.86 )
Ranked among companies with meaningful PS Ratio only.
RMD' s PS Ratio Range Over the Past 10 Years
Min: 2.77  Med: 4.48 Max: 6.51
Current: 4.86
2.77
6.51
Price-to-Free-Cash-Flow 28.27
RMD's Price-to-Free-Cash-Flow is ranked higher than
59% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.88 vs. RMD: 28.27 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
RMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.35  Med: 24.85 Max: 308.55
Current: 28.27
13.35
308.55
Price-to-Operating-Cash-Flow 23.69
RMD's Price-to-Operating-Cash-Flow is ranked lower than
55% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.90 vs. RMD: 23.69 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
RMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.7  Med: 18.63 Max: 44.03
Current: 23.69
10.7
44.03
EV-to-EBIT 23.23
RMD's EV-to-EBIT is ranked higher than
54% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. RMD: 23.23 )
Ranked among companies with meaningful EV-to-EBIT only.
RMD' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.8  Med: 17.5 Max: 48.6
Current: 23.23
10.8
48.6
EV-to-EBITDA 18.54
RMD's EV-to-EBITDA is ranked lower than
57% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. RMD: 18.54 )
Ranked among companies with meaningful EV-to-EBITDA only.
RMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.5  Med: 14.2 Max: 29.5
Current: 18.54
8.5
29.5
PEG Ratio 3.18
RMD's PEG Ratio is ranked lower than
57% of the 58 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. RMD: 3.18 )
Ranked among companies with meaningful PEG Ratio only.
RMD' s PEG Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.59 Max: 5.05
Current: 3.18
0.7
5.05
Shiller PE Ratio 37.81
RMD's Shiller PE Ratio is ranked higher than
53% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 43.41 vs. RMD: 37.81 )
Ranked among companies with meaningful Shiller PE Ratio only.
RMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 30.9  Med: 43.26 Max: 84.78
Current: 37.81
30.9
84.78
Current Ratio 4.77
RMD's Current Ratio is ranked lower than
56% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. RMD: 4.77 )
Ranked among companies with meaningful Current Ratio only.
RMD' s Current Ratio Range Over the Past 10 Years
Min: 0.87  Med: 4.19 Max: 6.44
Current: 4.77
0.87
6.44
Quick Ratio 4.00
RMD's Quick Ratio is ranked higher than
57% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. RMD: 4.00 )
Ranked among companies with meaningful Quick Ratio only.
RMD' s Quick Ratio Range Over the Past 10 Years
Min: 0.61  Med: 3.23 Max: 5.71
Current: 4
0.61
5.71
Days Inventory 105.23
RMD's Days Inventory is ranked higher than
61% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. RMD: 105.23 )
Ranked among companies with meaningful Days Inventory only.
RMD' s Days Inventory Range Over the Past 10 Years
Min: 100.51  Med: 132.76 Max: 168.51
Current: 105.23
100.51
168.51
Days Sales Outstanding 74.42
RMD's Days Sales Outstanding is ranked lower than
66% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. RMD: 74.42 )
Ranked among companies with meaningful Days Sales Outstanding only.
RMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 74.42  Med: 79.69 Max: 85.51
Current: 74.42
74.42
85.51
Days Payable 35.61
RMD's Days Payable is ranked lower than
61% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. RMD: 35.61 )
Ranked among companies with meaningful Days Payable only.
RMD' s Days Payable Range Over the Past 10 Years
Min: 35.61  Med: 46.2 Max: 60.16
Current: 35.61
35.61
60.16

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.90
RMD's Dividend Yield % is ranked higher than
68% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. RMD: 1.90 )
Ranked among companies with meaningful Dividend Yield % only.
RMD' s Dividend Yield % Range Over the Past 10 Years
Min: 0.41  Med: 1.88 Max: 2.26
Current: 1.9
0.41
2.26
Dividend Payout Ratio 0.57
RMD's Dividend Payout Ratio is ranked higher than
53% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. RMD: 0.57 )
Ranked among companies with meaningful Dividend Payout Ratio only.
RMD' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.32  Med: 0.44 Max: 0.57
Current: 0.57
0.32
0.57
3-Year Dividend Growth Rate 20.80
RMD's 3-Year Dividend Growth Rate is ranked higher than
73% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.60 vs. RMD: 20.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
RMD' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 20.8
Current: 20.8
0
20.8
Forward Dividend Yield % 1.93
RMD's Forward Dividend Yield % is ranked higher than
67% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. RMD: 1.93 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.90
RMD's 5-Year Yield-on-Cost % is ranked lower than
52% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. RMD: 1.90 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
RMD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.41  Med: 1.88 Max: 2.26
Current: 1.9
0.41
2.26
3-Year Average Share Buyback Ratio 0.30
RMD's 3-Year Average Share Buyback Ratio is ranked higher than
85% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.20 vs. RMD: 0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
RMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -44.2  Med: -2.5 Max: 2.6
Current: 0.3
-44.2
2.6

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 257.44
RMD's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.18 vs. RMD: 257.44 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
RMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.63  Med: 9.63 Max: 1270
Current: 257.44
1.63
1270
Price-to-Tangible-Book 18.34
RMD's Price-to-Tangible-Book is ranked lower than
94% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. RMD: 18.34 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
RMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.5  Med: 6.03 Max: 34.83
Current: 18.34
1.5
34.83
Price-to-Intrinsic-Value-Projected-FCF 1.76
RMD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
61% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. RMD: 1.76 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
RMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.35  Med: 3.25 Max: 22.95
Current: 1.76
1.35
22.95
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.07
RMD's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
83% of the 23 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. RMD: 1.07 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.09
RMD's Price-to-Median-PS-Value is ranked lower than
51% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. RMD: 1.09 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
RMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.43  Med: 1.04 Max: 2.43
Current: 1.09
0.43
2.43
Price-to-Peter-Lynch-Fair-Value 4.78
RMD's Price-to-Peter-Lynch-Fair-Value is ranked lower than
74% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.21 vs. RMD: 4.78 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
RMD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.73  Med: 1.5 Max: 6.32
Current: 4.78
0.73
6.32
Price-to-Graham-Number 4.97
RMD's Price-to-Graham-Number is ranked lower than
86% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. RMD: 4.97 )
Ranked among companies with meaningful Price-to-Graham-Number only.
RMD' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.12  Med: 2.76 Max: 14.87
Current: 4.97
1.12
14.87
Earnings Yield (Greenblatt) % 4.32
RMD's Earnings Yield (Greenblatt) % is ranked higher than
67% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. RMD: 4.32 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
RMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.1  Med: 5.7 Max: 9.3
Current: 4.32
2.1
9.3
Forward Rate of Return (Yacktman) % 9.87
RMD's Forward Rate of Return (Yacktman) % is ranked higher than
53% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. RMD: 9.87 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
RMD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.8  Med: 18.6 Max: 29
Current: 9.87
9.8
29

More Statistics

Revenue (TTM) (Mil) $2,029
EPS (TTM) $ 2.29
Beta0.81
Short Percentage of Float7.27%
52-Week Range $56.59 - 73.46
Shares Outstanding (Mil)141.82

Analyst Estimate

Jun17 Jun18 Jun19
Revenue (Mil $) 2,099 2,316 1,633
EPS ($) 2.93 3.33 2.22
EPS without NRI ($) 2.93 3.33 2.22
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.72%
Dividends per Share ($) 1.37 1.53 1.07
» More Articles for RMD

Headlines

Articles On GuruFocus.com
Big Data Yields Big Insights for Treatment of Central Sleep Apnea May 22 2017 
Clinical Trial Published in JAMA Offers New Hope for COPD Patients May 22 2017 
Introducing the Softest CPAP Mask from ResMed May 16 2017 
ResMed Unveils AirMini - the World's Smallest CPAP Apr 25 2017 
New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Slee Apr 06 2017 
ResMed to Announce Third Quarter Fiscal Year 2017 Results Mar 31 2017 
Columbia Wanger Boosts LivaNova, Sells Stericycle Aug 19 2016 
Battery Ventures-Backed Software Company Brightree LLC to Be Acquired for $800 Million Feb 23 2016 
Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
These 7 Growth Stocks Have Potential To Make You Rich Sep 14 2014 

More From Other Websites
Big Data Yields Big Insights for Treatment of Central Sleep Apnea May 22 2017
Clinical Trial Published in JAMA Offers New Hope for COPD Patients May 21 2017
Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel May 17 2017
ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare May 16 2017
Introducing the Softest CPAP Mask from ResMed May 16 2017
Edited Transcript of RMD earnings conference call or presentation 27-Apr-17 8:30pm GMT May 08 2017
Why Motley Fool Co-Founder David Gardner Likes ResMed Inc. May 04 2017
ETFs with exposure to ResMed, Inc. : May 2, 2017 May 02 2017
ResMed, Inc. :RMD-US: Earnings Analysis: Q3, 2017 By the Numbers : May 1, 2017 May 01 2017
Acquisitions Help Drive ResMed's Revenue 13% Higher May 01 2017
ResMed, Inc. – Value Analysis (NYSE:RMD) : April 28, 2017 Apr 28 2017
ResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates Apr 28 2017
ResMed tops 3Q profit forecasts Apr 27 2017
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2017 Apr 27 2017
ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : April 27, 2017 Apr 27 2017
Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More Apr 26 2017
ResMed Unveils AirMini - the World's Smallest CPAP Apr 25 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat